Abstract:Background: Neurofibromatosis Type 1 (NF1) is a congenital neurocutaneous disorder. As NF1 is incurable and presents with a wide range of physical and mental symptoms, knowledge of neurocognitive and behavioral functioning can be an important aid in understanding their functional impact, and developing treatment options. To date, studies in children with NF1 have shown dysfunction in several domains, but much less is known about cognition and behavior in adults with NF1. The present study describes the neuropsychological phenotype of adults with NF1 based on comprehensive clinical examination of cognition and behavior across multiple functions. Methods: Participants were 62 adults with NF1 (mean age 38.2 years; SD 13.4). All underwent individual clinical neuropsychological assessment at the Center of Excellence for Neuropsychiatry as part of regular care. Scores on all individual measures were standardized into z-scores based on the corresponding normative group data. The proportions of mean z-scores in the NF1 study group were calculated according to cut-off points (±1 to ±1.5 SD; > ±1.5 SD) and compared to the expected proportions in the normal population distribution. Cognition and behavior was tested against population means constructed by bootstrapping. Results: Performance on the cognitive measures oral reading speed, visuospatial copying, visuospatial immediate recall, visual learning/imprinting, and visual memory immediate recall in the NF1 group were lower than normative means. The behavioral measures indicated higher levels of dysfunction, including psychopathology. The proportions of the NF1 study group with lower cognitive performance and higher levels of behavioral dysfunction were larger than in the normal population distributions. In addition, domain-level results revealed that intelligence, attention/speed, memory, and social cognition reflect cognitive dysfunction. Moreover, levels of emotion perception problems, experienced executive dysfunction, internalizing psychopathology (e.g., anxiety, depression), and severe fatigue were significantly higher compared to the simulated population sample. The mean level of emotion regulation (coping strategies) did not differ significantly from the population. Conclusion: Identified cognitive and behavioral dysfunction in multiple domains indicates high vulnerability in adults with NF1 and underscores the importance of individualized neuropsychological assessment and treatment. Further research on the relationships between cognition and behavior (including fatigue) in NF1 is warranted.

Fungiform Papillae and Gustatory Function in Neurofibromatosis Type 1: A Case–Control Study

Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study

Investigation of nasal cavity alterations in individuals with neurofibromatosis type 1 using CBCT

Extensive Neurofibroma On The Palate In Neurofibromatosis Type 1: A Case Report.

Hospital Visits Associated With Oral Infections in Patients With Neurofibromatosis Type 1: A Register‐Based Analysis

Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort Study

The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review

Bone absorption and deformity in mandible as initial symptom and manifestation of neurofibromatosis type 1: A case report and literature review

Qol-30. Dietary Considerations For People With Nf1: A Systematic Review Of The Literature

Cranial Nerve Affection in Adolescents with Type 1 Diabetes Assessed by Corneal Confocal Microscopy, Smell and Taste Tests

Cognition and behavior in adults with neurofibromatosis type 1

Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study

Evaluation and Factors of Quality of Life Among Patients With Neurofibromatosis Type 1-Associated Craniofacial Plexiform Neurofibromas.

Clinical manifestations of neurofibromatosis type 1 – a diagnostic and management challenge

Alteration of taste perception, food neophobia and oral microbiota composition in children with food allergy

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey

Flavor and taste recognition impairments in people with type 1 diabetes

New insights into the molecular basis of spinal neurofibromatosis type 1

Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior

Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype

Pictorial Review and Retrospective Study of Their Frequency in a Cohort of Patients